Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.


Journal Article

PURPOSE: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. METHODS: In-111 pentetreotide (In-111 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. RESULTS: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. CONCLUSION: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

Full Text

Duke Authors

Cited Authors

  • Lin, K; Nguyen, BD; Ettinger, DS; Chin, BB

Published Date

  • January 1999

Published In

Volume / Issue

  • 24 / 1

Start / End Page

  • 24 - 28

PubMed ID

  • 9890489

Pubmed Central ID

  • 9890489

International Standard Serial Number (ISSN)

  • 0363-9762

Digital Object Identifier (DOI)

  • 10.1097/00003072-199901000-00006


  • eng

Conference Location

  • United States